Lead researcher behind VitaDAO’s first project reveals more about his work and why crypto provides an exciting new funding option for longevity scientists.
Later this...
Some news from us! Longevity.Technology's brand-new investment portal brings innovators and investors together.
As a part of our mission to support the companies that will...
Oisín Biotechnologies funding tops $9.5 million, with additional funding set to support preclinical development of its platform and investigational therapy for kidney and other age-related diseases.
Seattle-based...
Send in the senoblockers – Dorian and HitGen announce a research collaboration focused on DNA-encoded library-based drug discovery for age-related diseases.
HitGen, Inc today announced...
Investor states that mental health issues will be the "number one disease of the 21st century."
Fresh from announcing his involvement in a $200 million...
Dyno Therapeutics closes $100 million Series A led by Andreessen Horowitz to accelerate AI-powered gene therapy platform.
Dyno Therapeutics, Inc, a biotech applying AI to...
With the goal of bringing proactive, predictive care to all, Huma has $130 million financing from leading health and technology companies.
The investment arms of...
Pacific Asset Management has hired Dani Saurymper from AXA IM – new fund lined up for the healthcare manager.
Pacific Asset Management (PAM) has announced...
The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve.
Michael Greve, founder of...
Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...
FOXO Technologies' exclusive licence of epigenetic clocks PhenoAge and GrimAge from UCLA could be an insurance game-changer.
FOXO Technologies Inc has announced the licence of...
Sonia Arrison talks about her journey to becoming an early stage investor and what longevity means to her.
While longevity is now seeing increasing interest...
H&H Group expands Swisse healthy aging product line into growing NAD+ space with Niagen from ChromaDex.
Los Angeles-based ChromaDex has announced it entered into a strategic...
New partnership provides £6m in investment and grants to progress improved health in later life.
Nesta – the UK’s innovation foundation for social good –...
Silicon Valley investor Khosla Ventures joins esteemed group of global investors backing Turn Biotechnologies.
Turn Biotechnologies, a company developing novel RNA medicines for untreatable age-related...
Swiss-based Maximon already moving forward with companies focused on precision supplements and personalised longevity advice.
Already touted as a hotbed of longevity innovation, Switzerland is...
Highlights from longevity research, trials and funding in January 2021
Hundreds of companies are working to develop treatments to slow down aging and increase healthy...
Celeris bags €400k for creation of deep learning platform to support development of longevity drugs for Alzheimer's and other age-related diseases.
With a focus on...
Harvard researcher proposes the Daphnia water flea as an alternative to worms for building a scalable platform for antiaging drugs research.
In many ponds and...
Insilico closes $255 million to progress into human clinical trials and develop novel targets and also announces Teva Pharm collaboration.
Insilico Medicine, a company driving...
